Varicella zoster virus–infected cerebrovascular cells produce a proinflammatory environment
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To test whether varicella zoster virus (VZV) infection of human brain vascular cells and of lung fibroblasts directly increases proinflammatory cytokine levels, consistent with VZV as a causative agent in intracerebral VZV vasculopathy and giant-cell arteritis (GCA).
Methods: Conditioned supernatant from mock- and VZV-infected human brain vascular adventitial fibroblasts (HBVAFs), human perineurial cells (HPNCs), human brain vascular smooth muscle cells (HBVSMCs), and human fetal lung fibroblasts (HFLs) were collected at 72 hours postinfection and analyzed for levels of 30 proinflammatory cytokines using the Meso Scale Discovery Multiplex ELISA platform.
Results: Compared with mock infection, VZV infection led to significantly increased levels of the following: interleukin-8 (IL-8) in all cell lines examined; IL-6 in HBVAFs, HPNCs, and HFLs, with no change in HBVSMCs; and vascular endothelial growth factor A in HBVAFs, HBVSMCs, and HFLs, with a significant decrease in HPNCs. Other cytokines, including IL-2, IL-4, IL-15, IL-16, TGF-b, Eotaxin-1, Eotaxin-3, IP-10, MCP-1, and granulocyte macrophage colony-stimulating factor, were also significantly altered upon VZV infection in a cell type–specific manner.
Conclusions: VZV infection of vascular cells can directly produce a proinflammatory environment that may potentially lead to prolonged arterial wall inflammation and vasculitis. The VZV-mediated increase in IL-8 and IL-6 is consistent with that seen in the CSF of patients with intracerebral VZV vasculopathy, and the VZV-mediated increase in IL-6 is consistent with the cytokine's elevated levels in temporal arteries and plasma of patients with GCA.
GLOSSARY
- α-SMA=
- alpha–smooth muscle actin;
- BBB=
- blood-brain barrier;
- FBS=
- fetal bovine serum;
- FACS=
- fluorescence-activated cell sorting;
- GCA=
- giant-cell arteritis;
- GM-CSF=
- granulocyte macrophage colony-stimulating factor;
- HBVAF=
- human brain vascular adventitial fibroblast;
- HBVSMC=
- human brain vascular smooth muscle cell;
- HFL=
- human fetal lung fibroblast;
- HPNC=
- human perineurial cell;
- IFNγ=
- interferon gamma;
- IL=
- interleukin;
- TARC=
- thymus and activation-regulated chemokine;
- TNF-α=
- tumor necrosis factor alpha;
- TNF-β=
- tumor necrosis factor beta;
- TGF-β=
- transforming growth factor β;
- VZV=
- varicella zoster virus;
- VEGF-A=
- vascular endothelial growth factor A
Footnotes
Funding information and disclosures are provided at the end of the article. Go to Neurology.org/nn for full disclosure forms. The Article Processing Charge was funded by NIH AG032958.
- Received January 9, 2017.
- Accepted in final form May 16, 2017.
- Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Varicella zoster virus vasculopathyAnalysis of virus-infected arteriesM.A. Nagel, I. Traktinskiy, Y. Azarkh et al.Neurology, July 13, 2011 -
Article
Varicella-zoster virus vasculopathyImmune characteristics of virus-infected arteriesMaria A. Nagel, Igor Traktinskiy, Kurt R. Stenmark et al.Neurology, December 12, 2012 -
What's Happening
What's happening in Neurology® Neuroimmunology & Neuroinflammationet al.Neurology, April 16, 2018 -
Article
Targeted RNA Sequencing of Formalin-Fixed, Paraffin-Embedded Temporal Arteries From Giant Cell Arteritis Cases Reveals Viral SignaturesAndrew N. Bubak, Teresa Mescher, Michael Mariani et al.Neurology: Neuroimmunology & Neuroinflammation, September 07, 2021